Teva Asks U.S. Justices for Stay in Copaxone Case

The appeals court upheld some of nine patents involved in the drug, or portions thereof, but declared several invalid, shortening patent protection for the drug.

Reuters
Send in e-mailSend in e-mail
Reuters

Comments